• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Monday, September 25, 2023
Leadership News
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sports
    • Betting
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • 2023 Elections
  • Others
    • How-to
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sports
    • Betting
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • 2023 Elections
  • Others
    • How-to
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership News
No Result
View All Result
ADVERTISEMENT

COVID-19 Vaccine: Moderna To Sue Pfizer Over Patent Infringement

by Royal Ibeh
1 year ago
in Health
Reading Time: 2 mins read
Moderna
Share on WhatsAppShare on FacebookShare on TwitterTelegram

Moderna, based in Cambridge, Massachusetts, said it will be suing Pfizer and its German partner, BioNTech, for patent infringement in the development of the first COVID-19 vaccine.

Just a decade-old, Moderna, had been an innovator in the messenger RNA (mRNA) vaccine technology that enabled the unprecedented speed in developing the COVID-19 vaccine.

An approval process that previously took years was completed in months, due to the breakthrough in mRNA vaccines, which teach human cells how to make a protein that will trigger an immune response.

Moderna is alleging that Pfizer copied its mRNA technology it developed before the pandemic.

The lawsuit, which seeks undetermined monetary damages, was being filed in U.S. District Court in Massachusetts and the Regional Court of Dusseldorf in Germany, Moderna said in a press release on Friday.

Moderna alleged that Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before COVID-19 emerged in 2019 and exploded into global consciousness in early 2020.

Early in the pandemic, Moderna said it would not enforce its COVID-19 patents to help others develop their own vaccines, particularly for low and middle-income countries. But in March 2022, Moderna said it expected companies such as Pfizer and BioNTech to respect its intellectual property rights. It said it would not seek damages for any activity before March 8, 2022.

RELATED

PCOS: The Pains Women Go Through

PCOS: The Pains Women Go Through

16 hours ago
Setting Healthy Boundaries For Kids: Why, How To Do It

Setting Healthy Boundaries For Kids: Why, How To Do It

2 days ago
Nigeria Records 355 Successful Fibroids Treatment With HIFU Technology 

Nigeria Records 355 Successful Fibroids Treatment With HIFU Technology 

3 days ago
Malaria Prevention: SEEPCO Supports 150 Pregnant Women With LLINs In Lagos

Malaria Prevention: SEEPCO Supports 150 Pregnant Women With LLINs In Lagos

6 days ago

In a press statement, released by Moderna on Friday, the company said Pfizer/BioNTech appropriated two types of intellectual property.

One involved an mRNA structure that Moderna said its scientists began developing in 2010 and were the first to validate in human trials in 2015.

Pfizer and BioNTech took four different vaccine candidates into clinical testing, which included options that would have steered clear of Moderna’s innovative path. Pfizer and BioNTech, however, ultimately decided to proceed with a vaccine that has the same exact mRNA chemical modification to its vaccine, Moderna said.

The second alleged infringement involves the coding of a full-length spike protein that Moderna said its scientists developed while creating a vaccine for the coronavirus that causes Middle East Respiratory Syndrome (MERS).

Meanwhile, Pfizer is yet to respond to the allegations, as at the time of filing in the report.

SendShareTweetShare
HOW CHINESE DOCTOR RECOMMEND THIS MAGIC DRUGS THAT HELP WOMEN PREVENT AND TREAT BREAST CANCER AND ALSO HELP MEN PREVENT AND CURE PROSTATE ISSUE PERMANENTLY
ADVERTISEMENT
Previous Post

Zulum Directs Borno Agency To Unseal NNPP Office

Next Post

Ending Petrol Subsidy Difficult But Federal Govt Has No Option, Says MOMAN

YOU MAY LIKE

PCOS: The Pains Women Go Through
Health

PCOS: The Pains Women Go Through

16 hours ago
Setting Healthy Boundaries For Kids: Why, How To Do It
Health

Setting Healthy Boundaries For Kids: Why, How To Do It

2 days ago
Nigeria Records 355 Successful Fibroids Treatment With HIFU Technology 
Health

Nigeria Records 355 Successful Fibroids Treatment With HIFU Technology 

3 days ago
Malaria Prevention: SEEPCO Supports 150 Pregnant Women With LLINs In Lagos
Health

Malaria Prevention: SEEPCO Supports 150 Pregnant Women With LLINs In Lagos

6 days ago
Next Post
Petrol

Ending Petrol Subsidy Difficult But Federal Govt Has No Option, Says MOMAN

TRENDING

  • Mohbad: My Mother Against Me Returning To Nigeria Now — Bella Shmurda

    Mohbad: My Mother Against Me Returning To Nigeria Now — Bella Shmurda

    0 shares
    Share 0 Tweet 0
  • Meet 13 Popular Korean Actors, Actresses That Speak English Fluently

    0 shares
    Share 0 Tweet 0
  • JJC Skillz Teases New Project With Ex-wife, Funke Akindele

    0 shares
    Share 0 Tweet 0
  • UK Releases New Entry Requirement

    0 shares
    Share 0 Tweet 0
  • Meet 8 Artistes Signed By Marlian Records

    0 shares
    Share 0 Tweet 0

RECENT UPDATE

Kidnappers Devise New Tactics, Abduct Popular Musician’s Daughter In Kwara
News

Gunmen Kill Plateau Community Leader

by Achor Abimaje
45 seconds ago

Read more
APC NASS Candidates Protest Judge’s Refusal To Recuse Self
News

Ohanaeze Asks FCT Minister To Ban Activities Of Eze-Igbo

by Kunle Olasanmi
3 mins ago

Read more
Lawmakers Flee As Suspected Thugs Invade Benue Assembly, Smash Cars
News

Derogatory Statement: Benue Assembly Asks NBC To Abolish BBNaija

by Hembadoon Orsar
6 mins ago

Read more

© 2023 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sports
    • Betting
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • 2023 Elections
  • Others
    • How-to
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2023 Leadership Media Group - All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In